115 related articles for article (PubMed ID: 32887532)
1. Inhibitors of type II transmembrane serine proteases in the treatment of diseases of the respiratory tract - A review of patent literature.
Murza A; Dion SP; Boudreault PL; Désilets A; Leduc R; Marsault É
Expert Opin Ther Pat; 2020 Nov; 30(11):807-824. PubMed ID: 32887532
[TBL] [Abstract][Full Text] [Related]
2. DESC1 and MSPL activate influenza A viruses and emerging coronaviruses for host cell entry.
Zmora P; Blazejewska P; Moldenhauer AS; Welsch K; Nehlmeier I; Wu Q; Schneider H; Pöhlmann S; Bertram S
J Virol; 2014 Oct; 88(20):12087-97. PubMed ID: 25122802
[TBL] [Abstract][Full Text] [Related]
3. The Proteolytic Activation of (H3N2) Influenza A Virus Hemagglutinin Is Facilitated by Different Type II Transmembrane Serine Proteases.
Kühn N; Bergmann S; Kösterke N; Lambertz RLO; Keppner A; van den Brand JMA; Pöhlmann S; Weiß S; Hummler E; Hatesuer B; Schughart K
J Virol; 2016 May; 90(9):4298-4307. PubMed ID: 26889029
[TBL] [Abstract][Full Text] [Related]
4. TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein.
Kishimoto M; Uemura K; Sanaki T; Sato A; Hall WW; Kariwa H; Orba Y; Sawa H; Sasaki M
Viruses; 2021 Feb; 13(3):. PubMed ID: 33671076
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the catalytic domain of DESC1, a new member of the type II transmembrane serine proteinase family.
Kyrieleis OJ; Huber R; Ong E; Oehler R; Hunter M; Madison EL; Jacob U
FEBS J; 2007 Apr; 274(8):2148-60. PubMed ID: 17388811
[TBL] [Abstract][Full Text] [Related]
6. Recent progress on inhibitors of the type II transmembrane serine proteases, hepsin, matriptase and matriptase-2.
Damalanka VC; Janetka JW
Future Med Chem; 2019 Apr; 11(7):743-769. PubMed ID: 30945556
[TBL] [Abstract][Full Text] [Related]
7. Airway proteases: an emerging drug target for influenza and other respiratory virus infections.
Laporte M; Naesens L
Curr Opin Virol; 2017 Jun; 24():16-24. PubMed ID: 28414992
[TBL] [Abstract][Full Text] [Related]
8. Transcriptome profiling and protease inhibition experiments identify proteases that activate H3N2 influenza A and influenza B viruses in murine airways.
Harbig A; Mernberger M; Bittel L; Pleschka S; Schughart K; Steinmetzer T; Stiewe T; Nist A; Böttcher-Friebertshäuser E
J Biol Chem; 2020 Aug; 295(33):11388-11407. PubMed ID: 32303635
[TBL] [Abstract][Full Text] [Related]
9. The role of type II transmembrane serine protease-mediated signaling in cancer.
Tanabe LM; List K
FEBS J; 2017 May; 284(10):1421-1436. PubMed ID: 27870503
[TBL] [Abstract][Full Text] [Related]
10. Type II transmembrane serine proteases as potential target for anti-influenza drug discovery.
Shin WJ; Seong BL
Expert Opin Drug Discov; 2017 Nov; 12(11):1139-1152. PubMed ID: 28870104
[TBL] [Abstract][Full Text] [Related]
11.
Stopsack KH; Mucci LA; Antonarakis ES; Nelson PS; Kantoff PW
Cancer Discov; 2020 Jun; 10(6):779-782. PubMed ID: 32276929
[No Abstract] [Full Text] [Related]
12. Evolutionary history of type II transmembrane serine proteases involved in viral priming.
Forni D; Sironi M; Cagliani R
Hum Genet; 2022 Nov; 141(11):1705-1722. PubMed ID: 35122525
[TBL] [Abstract][Full Text] [Related]
13. Host serine proteases TMPRSS2 and TMPRSS11D mediate proteolytic activation and trypsin-independent infection in group A rotaviruses.
Sasaki M; Itakura Y; Kishimoto M; Tabata K; Uemura K; Ito N; Sugiyama M; Wastika CE; Orba Y; Sawa H
J Virol; 2021 May; 95(11):. PubMed ID: 33762412
[TBL] [Abstract][Full Text] [Related]
14. Targeting Proteases for Treating COVID-19.
Luan B; Huynh T; Cheng X; Lan G; Wang HR
J Proteome Res; 2020 Nov; 19(11):4316-4326. PubMed ID: 33090793
[TBL] [Abstract][Full Text] [Related]
15. Structure-based drug repositioning over the human TMPRSS2 protease domain: search for chemical probes able to repress SARS-CoV-2 Spike protein cleavages.
Singh N; Decroly E; Khatib AM; Villoutreix BO
Eur J Pharm Sci; 2020 Oct; 153():105495. PubMed ID: 32730844
[TBL] [Abstract][Full Text] [Related]
16. Potential Therapeutic Targeting of Coronavirus Spike Glycoprotein Priming.
Barile E; Baggio C; Gambini L; Shiryaev SA; Strongin AY; Pellecchia M
Molecules; 2020 May; 25(10):. PubMed ID: 32455942
[TBL] [Abstract][Full Text] [Related]
17. TMPRSS2 and TMPRSS4 facilitate trypsin-independent spread of influenza virus in Caco-2 cells.
Bertram S; Glowacka I; Blazejewska P; Soilleux E; Allen P; Danisch S; Steffen I; Choi SY; Park Y; Schneider H; Schughart K; Pöhlmann S
J Virol; 2010 Oct; 84(19):10016-25. PubMed ID: 20631123
[TBL] [Abstract][Full Text] [Related]
18. Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2.
Shirato K; Kawase M; Matsuyama S
J Virol; 2013 Dec; 87(23):12552-61. PubMed ID: 24027332
[TBL] [Abstract][Full Text] [Related]
19. TMPRSS11A activates the influenza A virus hemagglutinin and the MERS coronavirus spike protein and is insensitive against blockade by HAI-1.
Zmora P; Hoffmann M; Kollmus H; Moldenhauer AS; Danov O; Braun A; Winkler M; Schughart K; Pöhlmann S
J Biol Chem; 2018 Sep; 293(36):13863-13873. PubMed ID: 29976755
[TBL] [Abstract][Full Text] [Related]
20. In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection.
Vivek-Ananth RP; Rana A; Rajan N; Biswal HS; Samal A
Molecules; 2020 Aug; 25(17):. PubMed ID: 32842606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
